Delivery Order SPE2DB20D7059-SPE2DB25FPUC5

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,079.95 and is a Firm Fixed Price delivery order. It covers the procurement of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,867.85, is for the delivery of 4564885220 - CEFAZOLIN 1 G/50 ML-DEXTROSES, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,187.46 for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES. The contract is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA) Troop Support Medical, and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of May 23, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,228.56 firm fixed-price delivery order is for the medical supply item "CEFAZOLIN 2 G/50 ML-DEXTROSES" and has a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,881.43 Delivery Order is for the supply of 4564389001 - Cefazolin 2 GM Vials, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,393.30 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 GM VIALS, a type of antibiotic medication. The contract has a period of performance through June 12, 2025 and is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 Firm Fixed Price delivery order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award is a delivery order with a firm fixed price valued at $2,117.28. The award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES. The contract has an ultimate completion date of July 7, 2025 and was awarded on July 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,783.32 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPUC5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,979.10 firm fixed-price delivery order is for the supply of 4566410002 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The award does not have any set-aside designation, indicating open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/12/25, 9:26 AM